»ùÇà ¿äû ¸ñ·Ï¿¡ Ãß°¡
¹æ±¤¾Ï ½ÃÀåÀº 2023-2028³â°£ 24¾ï 4,960¸¸ ´Þ·¯ È®´ëµÇ°í, 11.4%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î È®´ëµÉ Àü¸ÁÀÔ´Ï´Ù. ÀÌ º¸°í¼´Â ¹æ±¤¾Ï ½ÃÀå¿¡ ´ëÇÑ Àü¹ÝÀûÀÎ ºÐ¼®, ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø, µ¿Çâ, ¼ºÀå ÃËÁø¿äÀÎ, °úÁ¦, ¾à 25°³ º¥´õ¿¡ ´ëÇÑ º¥´õ ºÐ¼® µîÀÇ Á¤º¸¸¦ ÀüÇØµå¸³´Ï´Ù.
ÇöÀçÀÇ ½ÃÀå ½Ã³ª¸®¿À, Ãֽе¿Çâ ¹× ¼ºÀå¿äÀÎ, Àüü ½ÃÀå ȯ°æ¿¡ ´ëÇÑ ÃֽŠºÐ¼®À» Á¦°øÇÕ´Ï´Ù. ¹æ±¤¾Ï ¹ßº´·ü Áõ°¡, ³ëÀÎ Àα¸ Áõ°¡, ¹æ±¤¾Ï ÀÎ½Ä Á¦°í Ä·ÆäÀÎ µîÀÌ ¹æ±¤¾Ï ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù.
½ÃÀå ¹üÀ§
±âÁØ ¿¬µµ
2024³â
Á¾·á ¿¬µµ
2028³â
¿¹Ãø ±â°£
2024-2028³â
¼ºÀå ¸ð¸àÅÒ
°¡¼Ó
Àü³â ´ëºñ(2024³â)
17.8%
CAGR
11.4%
ÁõºÐ ±Ý¾×
24¾ï 4,960¸¸ ´Þ·¯
ÀÌ º¸°í¼´Â ÇâÈÄ ¸î ³âµ¿¾È ¹æ±¤¾Ï ½ÃÀå ¼ºÀåÀ» ÁÖµµÇÒ ÁÖ¿ä ¿äÀÎ Áß Çϳª·Î ½Å¾àÀÇ ½ÂÀÎÀ» ²Å¾Ò½À´Ï´Ù. ¶ÇÇÑ, ºñħ½ÀÀû Áø´Ü µµ±¸ÀÇ Ã¤Åðú ¾Æ½Ã¾Æ Áö¿ªÀÇ ÀÇ·á °ü±¤ »ê¾÷ÀÇ ¼ºÀåÀº ½ÃÀå ¼ö¿ä¸¦ Å©°Ô Áõ°¡½Ãų °ÍÀ¸·Î ¿¹»óÇß½À´Ï´Ù.
¸ñÂ÷
Á¦1Àå ÁÖ¿ä ¿ä¾à
Á¦2Àå TechnavioÀÇ ºÐ¼®
°¡°Ý ¹Î°¨µµ, ¼ö¸íÁÖ±â, °í°´ ±¸ÀÔ ¹Ù½ºÄÏ, äÅà ºñÀ², ±¸ÀÔ ±âÁØ ºÐ¼®
ÀÎDzÀÇ Á߿伺°ú Â÷º°È ¿äÀÎ
È¥¶õ ¿äÀÎ
¼ºÀå ÃËÁø¿äÀΰú °úÁ¦ÀÇ ¿µÇâ
Á¦3Àå ½ÃÀå ±¸µµ
½ÃÀå »ýŰè
½ÃÀå Æ¯Â¡
¹ë·ùüÀÎ ºÐ¼®
Á¦4Àå ½ÃÀå ±Ô¸ð
½ÃÀåÀÇ Á¤ÀÇ
½ÃÀå ºÎ¹® ºÐ¼®
½ÃÀå ±Ô¸ð, 2023³â
½ÃÀå Àü¸Á, 2023-2028³â
Á¦5Àå ½ÃÀå ±Ô¸ð ½ÇÀû
¼¼°èÀÇ ¹æ±¤¾Ï ½ÃÀå, 2018-2022³â
Áúȯ À¯Çüº° ºÐ¼®, 2018-2022³â
¾àÁ¦ Ŭ·¡½ºº° ºÐ¼®, 2018-2022³â
Áö¿ªº° ºÐ¼®, 2018-2022³â
±¹°¡º° ºÐ¼®, 2018-2022³â
Á¦6Àå Á¤¼º ºÐ¼®
¹æ±¤¾Ï ¼¼°è ½ÃÀå ÀΰøÁö´É(AI) ¿µÇâ
Á¦7Àå Five Forces ºÐ¼®
Five Forces ¿ä¾à
¹ÙÀ̾îÀÇ ±³¼··Â
°ø±Þ ±â¾÷ÀÇ ±³¼··Â
½Å±Ô ÁøÃâ¾÷üÀÇ À§Çù
´ëüǰÀÇ À§Çù
°æÀï À§Çù
½ÃÀå ÇöȲ
Á¦8Àå ½ÃÀå ¼¼ºÐÈ : Áúȯ À¯Çüº°
½ÃÀå ºÎ¹®
ºñ±³ : Áúȯ À¯Çüº°
À̵¿ »óÇÇ¾Ï : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø, 2023-2028³â
±âŸ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø, 2023-2028³â
½ÃÀå ±âȸ : Áúȯ À¯Çüº°
Á¦9Àå ½ÃÀå ¼¼ºÐÈ : ¾àÁ¦ Ŭ·¡½ºº°
½ÃÀå ºÎ¹®
ºñ±³ ¾àÁ¦ Ŭ·¡½ºº°
¸é¿ªÄ¡·áÁ¦ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø, 2023-2028³â
ÈÇпä¹ýÁ¦ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø, 2023-2028³â
Ç¥Àû Ä¡·áÁ¦ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø, 2023-2028³â
½ÃÀå ±âȸ : ¾àÁ¦ Ŭ·¡½ºº°
Á¦10Àå °í°´ »óȲ
Á¦11Àå Áö¿ªº° »óȲ
Áö¿ªº° ¼¼ºÐÈ
Áö¿ªº° ºñ±³
ºÏ¹Ì : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø, 2023-2028³â
À¯·´ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø, 2023-2028³â
¾Æ½Ã¾Æ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø, 2023-2028³â
¼¼°è ±âŸ Áö¿ª : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø, 2023-2028³â
¹Ì±¹ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø, 2023-2028³â
µ¶ÀÏ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø, 2023-2028³â
ÀϺ» : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø, 2023-2028³â
¿µ±¹ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø, 2023-2028³â
Áß±¹ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø, 2023-2028³â
ij³ª´Ù : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø, 2023-2028³â
ÇÁ¶û½º : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø, 2023-2028³â
Àεµ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø, 2023-2028³â
ÀÌÅ»¸®¾Æ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø, 2023-2028³â
½ºÆäÀÎ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø, 2023-2028³â
½ÃÀå ±âȸ : Áö¿ª »óȲº°
Á¦12Àå ¼ºÀå ÃËÁø¿äÀÎ, °úÁ¦, ±âȸ ¹× ¼ºÀå ¾ïÁ¦¿äÀÎ
½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
½ÃÀåÀÌ ÇØ°áÇØ¾ß ÇÒ °úÁ¦
¼ºÀå ÃËÁø¿äÀΰú °úÁ¦ÀÇ ¿µÇâ
½ÃÀå ±âȸ¿Í ¼ºÀå ¾ïÁ¦¿äÀÎ
Á¦13Àå °æÀï ±¸µµ
°³¿ä
°æÀï ±¸µµ
È¥¶õ »óȲ
¾÷°è ¸®½ºÅ©
Á¦14Àå °æÀï ºÐ¼®
±â¾÷ °³¿ä
±â¾÷ ¼øÀ§ Áö¼ö
±â¾÷ÀÇ ½ÃÀå Æ÷Áö¼Å´×
Adaptimmune Therapeutics plc
Amneal Pharmaceuticals Inc.
Astellas Pharma Inc.
AstraZeneca Plc
Bristol Myers Squibb Co.
Eli Lilly and Co.
Endo International Plc
Ferring BV
Incyte Corp.
Johnson and Johnson Inc.
MEDYRA PHARMACEUTICAL
Merck and Co. Inc.
Merck KGaA
Pfizer Inc.
UroGen Pharma Ltd
Á¦15Àå ºÎ·Ï
LSH
Bladder Cancer Market 2024-2028
The bladder cancer market is forecasted to grow by USD 2449.6 mn during 2023-2028, accelerating at a CAGR of 11.4% during the forecast period. The report on the bladder cancer market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising incidence of bladder cancer, increasing geriatric population, and bladder cancer awareness campaigns.
Market Scope
Base Year 2024
End Year 2028
Series Year 2024-2028
Growth Momentum Accelerate
YOY 2024 17.8%
CAGR 11.4%
Incremental Value $2449.6 mn
Technavio's bladder cancer market is segmented as below:
By Disease Type
Transitional cell carcinoma
Others
By Drug Class
Immunotherapy drugs
Chemotherapy drugs
Target therapy drugs
By Geographical Landscape
North America
Europe
Asia
Rest of World (ROW)
This study identifies the approval of new drugs as one of the prime reasons driving the bladder cancer market growth during the next few years. Also, adoption of non-invasive diagnostic tools and growth of medical tourism industry in asia will lead to sizable demand in the market.
The report on the bladder cancer market covers the following areas:
Bladder Cancer Market sizing
Bladder Cancer Market forecast
Bladder Cancer Market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading bladder cancer market vendors that include Adaptimmune Therapeutics plc, Amneal Pharmaceuticals Inc., Astellas Pharma Inc., AstraZeneca Plc, Bavarian Nordic AS, Bristol Myers Squibb Co., Eli Lilly and Co., Endo International Plc, Ferring BV, Incyte Corp., Johnson and Johnson Inc., MEDYRA PHARMACEUTICAL, Merck and Co. Inc., Merck KGaA, Nanostics, Pfizer Inc., and UroGen Pharma Ltd. Also, the bladder cancer market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Disease Type
Executive Summary - Chart on Market Segmentation by Drug Class
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
Overview on factors of disruption
2.4 Impact of drivers and challenges
Impact of drivers and challenges in 2023 and 2028
3 Market Landscape
3.1 Market ecosystem
Parent Market
Data Table on - Parent Market
3.2 Market characteristics
Market characteristics analysis
3.3 Value chain analysis
4 Market Sizing
4.1 Market definition
Offerings of companies included in the market definition
4.2 Market segment analysis
4.3 Market size 2023
4.4 Market outlook: Forecast for 2023-2028
Chart on Global - Market size and forecast 2023-2028 ($ million)
Data Table on Global - Market size and forecast 2023-2028 ($ million)
Chart on Global Market: Year-over-year growth 2023-2028 (%)
Data Table on Global Market: Year-over-year growth 2023-2028 (%)
5 Historic Market Size
5.1 Global Bladder Cancer Market 2018 - 2022
Historic Market Size - Data Table on Global Bladder Cancer Market 2018 - 2022 ($ million)
5.2 Disease Type segment analysis 2018 - 2022
Historic Market Size - Disease Type Segment 2018 - 2022 ($ million)
5.3 Drug Class segment analysis 2018 - 2022
Historic Market Size - Drug Class Segment 2018 - 2022 ($ million)
5.4 Geography segment analysis 2018 - 2022
Historic Market Size - Geography Segment 2018 - 2022 ($ million)
5.5 Country segment analysis 2018 - 2022
Historic Market Size - Country Segment 2018 - 2022 ($ million)
6 Qualitative Analysis
6.1 Impact of Artificial Intelligence (AI) on Global Bladder Cancer Market
7 Five Forces Analysis
7.1 Five forces summary
Five forces analysis - Comparison between 2023 and 2028
7.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2023 and 2028
7.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2023 and 2028
7.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2023 and 2028
7.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2023 and 2028
7.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2023 and 2028
7.7 Market condition
Chart on Market condition - Five forces 2023 and 2028
8 Market Segmentation by Disease Type
8.1 Market segments
Chart on Disease Type - Market share 2023-2028 (%)
Data Table on Disease Type - Market share 2023-2028 (%)
8.2 Comparison by Disease Type
Chart on Comparison by Disease Type
Data Table on Comparison by Disease Type
8.3 Transitional cell carcinoma - Market size and forecast 2023-2028
Chart on Transitional cell carcinoma - Market size and forecast 2023-2028 ($ million)
Data Table on Transitional cell carcinoma - Market size and forecast 2023-2028 ($ million)
Chart on Transitional cell carcinoma - Year-over-year growth 2023-2028 (%)
Data Table on Transitional cell carcinoma - Year-over-year growth 2023-2028 (%)
8.4 Others - Market size and forecast 2023-2028
Chart on Others - Market size and forecast 2023-2028 ($ million)
Data Table on Others - Market size and forecast 2023-2028 ($ million)
Chart on Others - Year-over-year growth 2023-2028 (%)
Data Table on Others - Year-over-year growth 2023-2028 (%)
8.5 Market opportunity by Disease Type
Market opportunity by Disease Type ($ million)
Data Table on Market opportunity by Disease Type ($ million)
9 Market Segmentation by Drug Class
9.1 Market segments
Chart on Drug Class - Market share 2023-2028 (%)
Data Table on Drug Class - Market share 2023-2028 (%)
9.2 Comparison by Drug Class
Chart on Comparison by Drug Class
Data Table on Comparison by Drug Class
9.3 Immunotherapy drugs - Market size and forecast 2023-2028
Chart on Immunotherapy drugs - Market size and forecast 2023-2028 ($ million)
Data Table on Immunotherapy drugs - Market size and forecast 2023-2028 ($ million)
Chart on Immunotherapy drugs - Year-over-year growth 2023-2028 (%)
Data Table on Immunotherapy drugs - Year-over-year growth 2023-2028 (%)
9.4 Chemotherapy drugs - Market size and forecast 2023-2028
Chart on Chemotherapy drugs - Market size and forecast 2023-2028 ($ million)
Data Table on Chemotherapy drugs - Market size and forecast 2023-2028 ($ million)
Chart on Chemotherapy drugs - Year-over-year growth 2023-2028 (%)
Data Table on Chemotherapy drugs - Year-over-year growth 2023-2028 (%)
9.5 Target therapy drugs - Market size and forecast 2023-2028
Chart on Target therapy drugs - Market size and forecast 2023-2028 ($ million)
Data Table on Target therapy drugs - Market size and forecast 2023-2028 ($ million)
Chart on Target therapy drugs - Year-over-year growth 2023-2028 (%)
Data Table on Target therapy drugs - Year-over-year growth 2023-2028 (%)
9.6 Market opportunity by Drug Class
Market opportunity by Drug Class ($ million)
Data Table on Market opportunity by Drug Class ($ million)
10 Customer Landscape
10.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
11 Geographic Landscape
11.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2023-2028 (%)
Data Table on Market share By Geographical Landscape 2023-2028 (%)
11.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
11.3 North America - Market size and forecast 2023-2028
Chart on North America - Market size and forecast 2023-2028 ($ million)
Data Table on North America - Market size and forecast 2023-2028 ($ million)
Chart on North America - Year-over-year growth 2023-2028 (%)
Data Table on North America - Year-over-year growth 2023-2028 (%)
11.4 Europe - Market size and forecast 2023-2028
Chart on Europe - Market size and forecast 2023-2028 ($ million)
Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Chart on Europe - Year-over-year growth 2023-2028 (%)
Data Table on Europe - Year-over-year growth 2023-2028 (%)
11.5 Asia - Market size and forecast 2023-2028
Chart on Asia - Market size and forecast 2023-2028 ($ million)
Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Chart on Asia - Year-over-year growth 2023-2028 (%)
Data Table on Asia - Year-over-year growth 2023-2028 (%)
11.6 Rest of World (ROW) - Market size and forecast 2023-2028
Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
11.7 US - Market size and forecast 2023-2028
Chart on US - Market size and forecast 2023-2028 ($ million)
Data Table on US - Market size and forecast 2023-2028 ($ million)
Chart on US - Year-over-year growth 2023-2028 (%)
Data Table on US - Year-over-year growth 2023-2028 (%)
11.8 Germany - Market size and forecast 2023-2028
Chart on Germany - Market size and forecast 2023-2028 ($ million)
Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Chart on Germany - Year-over-year growth 2023-2028 (%)
Data Table on Germany - Year-over-year growth 2023-2028 (%)
11.9 Japan - Market size and forecast 2023-2028
Chart on Japan - Market size and forecast 2023-2028 ($ million)
Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Chart on Japan - Year-over-year growth 2023-2028 (%)
Data Table on Japan - Year-over-year growth 2023-2028 (%)
11.10 UK - Market size and forecast 2023-2028
Chart on UK - Market size and forecast 2023-2028 ($ million)
Data Table on UK - Market size and forecast 2023-2028 ($ million)
Chart on UK - Year-over-year growth 2023-2028 (%)
Data Table on UK - Year-over-year growth 2023-2028 (%)
11.11 China - Market size and forecast 2023-2028
Chart on China - Market size and forecast 2023-2028 ($ million)
Data Table on China - Market size and forecast 2023-2028 ($ million)
Chart on China - Year-over-year growth 2023-2028 (%)
Data Table on China - Year-over-year growth 2023-2028 (%)
11.12 Canada - Market size and forecast 2023-2028
Chart on Canada - Market size and forecast 2023-2028 ($ million)
Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Chart on Canada - Year-over-year growth 2023-2028 (%)
Data Table on Canada - Year-over-year growth 2023-2028 (%)
11.13 France - Market size and forecast 2023-2028
Chart on France - Market size and forecast 2023-2028 ($ million)
Data Table on France - Market size and forecast 2023-2028 ($ million)
Chart on France - Year-over-year growth 2023-2028 (%)
Data Table on France - Year-over-year growth 2023-2028 (%)
11.14 India - Market size and forecast 2023-2028
Chart on India - Market size and forecast 2023-2028 ($ million)
Data Table on India - Market size and forecast 2023-2028 ($ million)
Chart on India - Year-over-year growth 2023-2028 (%)
Data Table on India - Year-over-year growth 2023-2028 (%)
11.15 Italy - Market size and forecast 2023-2028
Chart on Italy - Market size and forecast 2023-2028 ($ million)
Data Table on Italy - Market size and forecast 2023-2028 ($ million)
Chart on Italy - Year-over-year growth 2023-2028 (%)
Data Table on Italy - Year-over-year growth 2023-2028 (%)
11.16 Spain - Market size and forecast 2023-2028
Chart on Spain - Market size and forecast 2023-2028 ($ million)
Data Table on Spain - Market size and forecast 2023-2028 ($ million)
Chart on Spain - Year-over-year growth 2023-2028 (%)
Data Table on Spain - Year-over-year growth 2023-2028 (%)
11.17 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ million)
Data Tables on Market opportunity By Geographical Landscape ($ million)
12 Drivers, Challenges, and Opportunity/Restraints
12.1 Market drivers
12.2 Market challenges
12.3 Impact of drivers and challenges
Impact of drivers and challenges in 2023 and 2028
12.4 Market opportunities/restraints
13 Competitive Landscape
13.1 Overview
13.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
13.3 Landscape disruption
Overview on factors of disruption
13.4 Industry risks
Impact of key risks on business
14 Competitive Analysis
14.1 Companies profiled
14.2 Company ranking index
14.3 Market positioning of companies
Matrix on companies position and classification
14.4 Adaptimmune Therapeutics plc
Adaptimmune Therapeutics plc - Overview
Adaptimmune Therapeutics plc - Product / Service
Adaptimmune Therapeutics plc - Key offerings
SWOT
14.5 Amneal Pharmaceuticals Inc.
Amneal Pharmaceuticals Inc. - Overview
Amneal Pharmaceuticals Inc. - Business segments
Amneal Pharmaceuticals Inc. - Key news
Amneal Pharmaceuticals Inc. - Key offerings
Amneal Pharmaceuticals Inc. - Segment focus
SWOT
14.6 Astellas Pharma Inc.
Astellas Pharma Inc. - Overview
Astellas Pharma Inc. - Product / Service
Astellas Pharma Inc. - Key offerings
SWOT
14.7 AstraZeneca Plc
AstraZeneca Plc - Overview
AstraZeneca Plc - Product / Service
AstraZeneca Plc - Key news
AstraZeneca Plc - Key offerings
SWOT
14.8 Bristol Myers Squibb Co.
Bristol Myers Squibb Co. - Overview
Bristol Myers Squibb Co. - Product / Service
Bristol Myers Squibb Co. - Key news
Bristol Myers Squibb Co. - Key offerings
SWOT
14.9 Eli Lilly and Co.
Eli Lilly and Co. - Overview
Eli Lilly and Co. - Product / Service
Eli Lilly and Co. - Key offerings
SWOT
14.10 Endo International Plc
Endo International Plc - Overview
Endo International Plc - Business segments
Endo International Plc - Key news
Endo International Plc - Key offerings
Endo International Plc - Segment focus
SWOT
14.11 Ferring BV
Ferring BV - Overview
Ferring BV - Product / Service
Ferring BV - Key news
Ferring BV - Key offerings
SWOT
14.12 Incyte Corp.
Incyte Corp. - Overview
Incyte Corp. - Product / Service
Incyte Corp. - Key offerings
SWOT
14.13 Johnson and Johnson Inc.
Johnson and Johnson Inc. - Overview
Johnson and Johnson Inc. - Business segments
Johnson and Johnson Inc. - Key news
Johnson and Johnson Inc. - Key offerings
Johnson and Johnson Inc. - Segment focus
SWOT
14.14 MEDYRA PHARMACEUTICAL
MEDYRA PHARMACEUTICAL - Overview
MEDYRA PHARMACEUTICAL - Product / Service
MEDYRA PHARMACEUTICAL - Key offerings
SWOT
14.15 Merck and Co. Inc.
Merck and Co. Inc. - Overview
Merck and Co. Inc. - Business segments
Merck and Co. Inc. - Key news
Merck and Co. Inc. - Key offerings
Merck and Co. Inc. - Segment focus
SWOT
14.16 Merck KGaA
Merck KGaA - Overview
Merck KGaA - Business segments
Merck KGaA - Key news
Merck KGaA - Key offerings
Merck KGaA - Segment focus
SWOT
14.17 Pfizer Inc.
Pfizer Inc. - Overview
Pfizer Inc. - Product / Service
Pfizer Inc. - Key news
Pfizer Inc. - Key offerings
SWOT
14.18 UroGen Pharma Ltd
UroGen Pharma Ltd - Overview
UroGen Pharma Ltd - Product / Service
UroGen Pharma Ltd - Key offerings
SWOT
15 Appendix
15.1 Scope of the report
15.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
15.3 Currency conversion rates for US$
Currency conversion rates for US$
15.4 Research methodology
15.5 Data procurement
15.6 Data validation
15.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
15.8 Data synthesis
15.9 360 degree market analysis
360 degree market analysis
15.10 List of abbreviations